Rothenberg Stephen Michael
Transaction: 05/28/2026
BUY
Change
+13,160
Price
$32.68
Filing
06/01/2026
Type
BUY
Tyra Biosciences, Inc.
TYRA • Biotechnology
Strong market move
TYRA+15.25%
vs. previous close $24.86
$28.65
▲ +3.79 (+15.25%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$1.89B
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.02Healthy liquidity · 14.67Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:50 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$28.65
Change15.25%
Shares Out65.99M
Market Cap$1.89B
Enterprise Value$1.54B
52W Range9.96 - 40.65
Beta0.77
P/E-12.73
P/B5.35
P/FCF-17.20
EV/EBITDA-10.01
EV/FCF-13.98
Price$28.65
Change15.25%
Shares Out65.99M
Market Cap$1.89B
Enterprise Value$1.54B
52W Range9.96 - 40.65
Beta0.77
P/E-12.73
P/B5.35
P/FCF-17.20
EV/EBITDA-10.01
EV/FCF-13.98
Earnings Yield-7.86%
FCF Yield-5.81%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.02
Current Ratio14.67
Quick Ratio14.67
Target$48.00
Target Upside67.54%
Target Median$48.00
Target Range42.00 - 54.00
Volume508.25K
Avg Volume899.15K
EPS Surprise-0.04
Investment DNA
How strong this company looks for long-term investors
40
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
53/100
Why this score▼
Manageable debt level · 0.02Healthy liquidity · 14.67Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 7 analyst votes · 2026-09-05
100/100
Bullish
Bullish
7
Hold
0
Bearish
0
Price Target
2026-08-14
Low
$42.00
Mean
$47.00
Median
$45.00
High
$54.00
Insider Transactions
Recent executive and insider activity
MORE ROBERT J
Transaction: 05/28/2026
BUY
Change
+13,160
Price
$32.68
Filing
06/01/2026
Type
BUY
Gulfo Adele M.
Transaction: 05/28/2026
BUY
Change
+13,160
Price
$32.68
Filing
06/01/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Rothenberg Stephen Michael | BUY | +13,160 | $32.68 | 05/28/2026 | 06/01/2026 |
| MORE ROBERT J | BUY | +13,160 | $32.68 | 05/28/2026 | 06/01/2026 |
| Gulfo Adele M. | BUY | +13,160 | $32.68 | 05/28/2026 | 06/01/2026 |
| Simson Jake | BUY | +13,160 | $32.68 | 05/28/2026 | 06/01/2026 |
| Moran Susan | BUY | +13,160 | $32.68 | 05/28/2026 | 06/01/2026 |
| Verjee Rehan | BUY | +13,160 | $32.68 | 05/28/2026 | 06/01/2026 |
| RA CAPITAL MANAGEMENT, L.P. | BUY | +13,160 | $32.68 | 05/28/2026 | 06/01/2026 |
| Rueb Yuliya | BUY | +28,000 | $33.93 | 05/05/2026 | 05/07/2026 |
| Rueb Yuliya | BUY | +8,333 | Not reported | 05/05/2026 | 05/07/2026 |
| Ashar Bhavesh | BUY | +15,013 | Not reported | 05/05/2026 | 05/07/2026 |
| Ashar Bhavesh | BUY | +50,295 | $33.93 | 05/05/2026 | 05/07/2026 |
| Harris Todd | BUY | +265,000 | $33.93 | 05/05/2026 | 05/07/2026 |
| Harris Todd | BUY | +79,000 | Not reported | 05/05/2026 | 05/07/2026 |
| Fuhrman Alan | BUY | +20,000 | Not reported | 05/05/2026 | 05/07/2026 |
| Fuhrman Alan | BUY | +67,000 | $33.93 | 05/05/2026 | 05/07/2026 |
| Warner Douglas J | BUY | +25,000 | Not reported | 05/05/2026 | 05/07/2026 |
| Warner Douglas J | BUY | +85,000 | $33.93 | 05/05/2026 | 05/07/2026 |
| Dable Habib J | OTHER | 0 | Not reported | 04/16/2026 | 04/20/2026 |
| Dable Habib J | BUY | +44,400 | $35.12 | 04/16/2026 | 04/20/2026 |
| Rueb Yuliya | OTHER | +26,875 | $21.57 | 04/01/2026 | 04/02/2026 |